Square Pharmaceuticals Ltd.

Square-Pharma-logoSQUARE today symbolizes a name – a state of mind. But its journey to the growth and prosperity has been no bed of roses. From the inception in 1958, it has today burgeoned into one of the top line conglomerates in Bangladesh. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and is now on its way to becoming a high performance global player.

SQUARE Pharmaceuticals Limited is the largest pharmaceutical company in Bangladesh and it has been continuously in the 1st position among all national and multinational companies since 1985. It was established in 1958 and converted into a public limited company in 1991. The sales turnover of SPL was more than Taka 11.46 Billion (US$ 163.71 million) with about 16.43% market share (April 2009– March 2010) having a growth rate of about 16.72%.

SQUARE Pharmaceuticals Limited has extended its range of services towards the highway of global market. It pioneered exports of medicines from Bangladesh in 1987 and has been exporting antibiotics and other pharmaceutical products. This extension in business and services has manifested the credibility of Square Pharmaceuticals Limited.

SQUARE Pharmaceuticals Ltd. (SPL) has three GMP compliant production sites. SPL product range covers: tablet, capsule, liquid orals, inhaler, injectable, suppository, topical preparations like powder, cream, ointment etc. All the plants at Dhaka site are built as per the GMP requirements of US-FDA. UNICEF, Copenhagen has approved Solid Dosage plant of Dhaka Site in 2002 for its Global Supply. The Facility is UK-MHRA approved since 2007 and TGA from 2012. Cephalosporin plant at Dhaka site is a standalone, state-of-the-art manufacturing facility and is TGA certified from 2012. Square is the first to introduce ‘Modular Aseptic Compact’ system to produce recombinant human insulin in Bangladesh. Objective is to manufacture world class insulin preparations at an affordable price.

Dhaka Plant

The Dhaka plant is about 50 km away in the north of the capital city. Bovis Lend Lease, UK designed this plant. This is a state of the art manufacturing facility for oral solid dosage forms and all facilities have been developed meeting the requirements of cGMP CFR 21. Dhaka Unit started its operation at the end of 2002.

  • General Production Building
  • Cephalosporins Unit
  • Small Volume Parenteral & Ophthalmic Unit
  • Insulin Unit
  • MDI Unit

Pabna Plant

The Pabna plant is the 1st manufacturing facility of SQUARE Pharmaceuticals Ltd. and started operation in 1958. It is a modern plant that fully complies with WHO – cGMP Requirements. It has earned ISO 9001 Certificate in 1998, for which Auditor was Orion Registrar Inc., USA. Again, it’s Quality Management System upgraded to 2008 version in 2002.

  • Hormone & Steroid Unit
  • Liquid Unit
  • Penicillin Unit
  • Animal Health Unit
  • Pesticide Unit
  • API Unit

SQUARE has invested in state of the art formulation plants aligned to regulated market standards. Six manufacturing units of the Dhaka site can produce pharmaceutical products maintaining cGMP requirement for highly regulated markets in Europe, Australia and USA. Other five manufacturing units at Pabna site are producing finished formulations targeting markets in ASEAN, SAARC and marketing in RoW region. We have 700 product approvals for export markets and 900 product approvals for Bangladesh market.

SQUARE Pharmaceuticals Ltd. is already supplying products to the following international markets:

Europe: UK, Denmark, The Netherlands

Asia: Afghanistan, Bhutan, Cambodia, Fiji, Hong Kong, Iraq, Korea, Macau, Malaysia, Maldives, Myanmar, Nepal, Papua New Guinea, Palau, Sri Lanka, Tajikistan, The Philippines, Uzbekistan, Vietnam

Africa: Eritrea, Ivory Coast, Kenya, Libya, Malawi, Mauritania, Mauritius, Mozambique, Nigeria, Somalia, Tanzania, Uganda

Central and South America: Belize, Costa Rica, Suriname

Highlights of the Export Operations
  • Exports pharmaceutical finished products since 1995
  • Offers quality products at competitive price
  • Offers more than 300 off-patent and on-patent molecules in different dosage forms
  • Offers facilities for contract manufacturing
  • Offers services for product development with subsequent technology transfer
  • Provides assistance in product promotion and training in overseas markets

Contacts:

SQUARE Centre, 48, Mohakhali C/A, Dhaka 1212, Bangladesh.

Phone: +88-02-9859007, +88-02-8833047-56

Fax: +88-02-8834941, +88-02-8828768

Email: info@squaregroup.com, intlmkt@squaregroup.com, hrd@squaregroup.com

Web: www.squarepharma.com.bd